Literature DB >> 6466552

Chronic alveolar hydatidosis and secondary amyloidosis: pathological aspects of the disease in four strains of mice.

T O Alkarmi, Z Ali-Khan.   

Abstract

Amyloidogenic potentials of alveolar hydatid cyst, the larval stage of Echinococcus multilocularis, were studied in BALB/c, C57BL/6J, CBA/J and A/JAX strains of mice. To determine strain susceptibility and sensitivity of various soft organs to amyloidosis, the intensity of inflammation and mean weights of the larval cyst masses from each host strain were correlated at various time intervals postinfection (p.i.) with the onset and amount of splenic, hepatic and kidney amyloid deposits. The onset and incidence of amyloidosis in these four host strains corresponded with the intensity of hepatic inflammation and not with the load of the parasite biomass. Hydatid mice spleens were more sensitive to amyloid deposition than livers or kidneys. Splenic amyloid deposits appeared at 6 weeks p.i. in BALB/c and C57BL/6J mice and at 8 and 12 weeks p.i. in CBA/J and A/JAX mice, respectively. The latter strain was relatively resistant to hydatid-induced amyloidosis. At 12 weeks p.i., amyloid-mediated changes in the spleens, livers and kidneys of the susceptible host strains were much more severe than in the A/JAX strain. In conclusion, alveolar hydatid cyst is highly amyloidogenic and provides a promising substitute for the study of induction and pathogenesis of secondary amyloidosis.

Entities:  

Mesh:

Year:  1984        PMID: 6466552      PMCID: PMC2040984     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  12 in total

1.  Animal model for human disease: spontaneous and induced amyloidosis.

Authors:  A S Cohen; T Shirahama
Journal:  Am J Pathol       Date:  1972-08       Impact factor: 4.307

Review 2.  Amyloidosis.

Authors:  A S Cohen
Journal:  N Engl J Med       Date:  1967-09-07       Impact factor: 91.245

3.  The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase.

Authors:  S L Silverman; E S Cathcart; M Skinner; A S Cohen
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

4.  Echinococcus multilocularis: cell-mediated immune response in early and chronic alveolar murine hydatidosis.

Authors:  Z Ali-Khan
Journal:  Exp Parasitol       Date:  1978-12       Impact factor: 2.011

5.  The role of inflammatory cells in the pathogenesis of amyloidosis.

Authors:  R Kisilevsky; M Axelrad; W Corbett; S Brunet; F Scott
Journal:  Lab Invest       Date:  1977-12       Impact factor: 5.662

6.  Experimental amyloidosis. Role of antigenicity and rapid induction.

Authors:  D T Janigan; R L Druet
Journal:  Am J Pathol       Date:  1966-06       Impact factor: 4.307

7.  Experimental amyloidosis. II. Light and electron microscopic observations of liver.

Authors:  G D Sorenson; W A Heefner; J B Kirkpatrick
Journal:  Am J Pathol       Date:  1964-04       Impact factor: 4.307

8.  Experimental murine amyloidosis: experience with Candida albicans as an amyloidogenic agent and liver biopsy as a diagnostic tool.

Authors:  A Savaga; C R Tribe
Journal:  J Pathol       Date:  1979-04       Impact factor: 7.996

9.  Practical stereological methods for morphometric cytology.

Authors:  E R Weibel; G S Kistler; W F Scherle
Journal:  J Cell Biol       Date:  1966-07       Impact factor: 10.539

10.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.

Authors:  K P McAdam; J D Sipe
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  8 in total

1.  Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; Z Ali-Khan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Echinococcus multilocularis: characterization of an alveolar hydatid cyst-induced amyloid enhancing factor.

Authors:  T Alkarmi; Z Alshakarchi; K Behbehani; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1989-10

3.  Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis.

Authors:  G V Abankwa; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1988-02

4.  Biochemical nature and cellular origin of amyloid enhancing factor (AEF) as determined by anti-AEF antibody.

Authors:  K Alizadeh-Khiavi; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1988-10

5.  Pathogenesis of secondary amyloidosis in an alveolar hydatid cyst-mouse model: histopathology and immuno/enzyme-histochemical analysis of splenic marginal zone cells during amyloidogenesis.

Authors:  T Du; Z Ali-Khan
Journal:  J Exp Pathol (Oxford)       Date:  1990-06

6.  Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis.

Authors:  Burkhard J Manfras; Stefan Reuter; Thomas Wendland; Peter Kern
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract.

Authors:  Z Ali-Khan; R Quirion; Y Robitaille; K Alizadeh-Khiavi; T Du
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Secondary amyloidosis in normal and immunocompromised mice infected with Schistosoma japonicum.

Authors:  A J Luty; C D Mackenzie; N A Moloney
Journal:  Br J Exp Pathol       Date:  1987-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.